MedPath

Northwestern University Human Resources

Northwestern University Human Resources logo
🇺🇸United States
Ownership
Private
Established
1851-01-28
Employees
5K
Market Cap
-
Website
https://www.venturecat.northwestern.edu

Vulvar Mucosal Specialty Clinic Chart Review

Terminated
Conditions
Lichen Sclerosus
Vulvar Disease
Vulvodynia
Lichen Planus
First Posted Date
2016-08-26
Last Posted Date
2020-10-09
Lead Sponsor
Northwestern University
Target Recruit Count
719
Registration Number
NCT02881229
Locations
🇺🇸

Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States

Vulvar Scarring Grading Scale for Lichen Sclerosus

Terminated
Conditions
Lichen Sclerosus et Atrophicus
Lichen Sclerosus
First Posted Date
2016-08-26
Last Posted Date
2020-10-09
Lead Sponsor
Northwestern University
Target Recruit Count
30
Registration Number
NCT02880904
Locations
🇺🇸

Northwestern University Feinberg School of Medicine, Department of Dermatology, Chicago, Illinois, United States

Cocoa to Improve Walking Performance in Peripheral Artery Disease

Not Applicable
Completed
Conditions
Peripheral Artery Disease
Interventions
Drug: Placebo
First Posted Date
2016-08-24
Last Posted Date
2020-08-06
Lead Sponsor
Northwestern University
Target Recruit Count
44
Registration Number
NCT02876887
Locations
🇺🇸

Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States

Anti-Inflammatory Agent in Sinusitis

Phase 2
Completed
Conditions
Nasal Polyps
Interventions
Drug: AZ compound
Drug: Intranasal corticosteroid
Other: Collection of Biological Specimens
Drug: Placebo
First Posted Date
2016-08-22
Last Posted Date
2022-05-25
Lead Sponsor
Northwestern University
Target Recruit Count
43
Registration Number
NCT02874144

Durvalumab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis

Phase 1
Withdrawn
Conditions
Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase
Primary Myelofibrosis
Interventions
Biological: Durvalumab
Other: Laboratory Biomarker Analysis
First Posted Date
2016-08-18
Last Posted Date
2019-08-20
Lead Sponsor
Northwestern University
Registration Number
NCT02871323
Locations
🇺🇸

Northwestern University, Chicago, Illinois, United States

Reducing the Effects of Active Surveillance Stress, Uncertainty and Rumination Thru Engagement in Mindfulness Education

Not Applicable
Completed
Conditions
Prostate Cancer
Interventions
Behavioral: Health promotion
First Posted Date
2016-08-18
Last Posted Date
2023-03-13
Lead Sponsor
Northwestern University
Target Recruit Count
225
Registration Number
NCT02871752
Locations
🇺🇸

Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

🇺🇸

University of Michigan, Ann Arbor, Michigan, United States

🇺🇸

Northwestern University, Chicago, Illinois, United States

and more 1 locations

A Smart, "Always -On" Health Monitoring System

Completed
Conditions
Premature Birth
Interventions
Device: Skin Sensor
First Posted Date
2016-08-12
Last Posted Date
2022-06-14
Lead Sponsor
Northwestern University
Target Recruit Count
38
Registration Number
NCT02865070
Locations
🇺🇸

Lurie Children's Hospital, Chicago, Illinois, United States

Enhanced Recovery After Surgery Gynecology Oncology

Not Applicable
Completed
Conditions
Malignant Female Reproductive System Neoplasm
Interventions
Procedure: No Intervention Conventional Strategy
Procedure: ERAS
First Posted Date
2016-08-12
Last Posted Date
2023-11-02
Lead Sponsor
Northwestern University
Target Recruit Count
120
Registration Number
NCT02864277
Locations
🇺🇸

Prentice Women's Hospital, Chicago, Illinois, United States

Online Positive Emotion Skills Intervention for Symptoms of Depression

Not Applicable
Completed
Conditions
Affect
Depression
Psychological Stress
Interventions
Behavioral: Positive Affect Skills Training
Behavioral: 5-week Emotion Reporting
First Posted Date
2016-08-10
Last Posted Date
2023-10-27
Lead Sponsor
Northwestern University
Target Recruit Count
677
Registration Number
NCT02861755
Locations
🇺🇸

Northwestern University, Feinberg School of Medicine, MSS Dept, Chicago, Illinois, United States

Volasertib and Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

Phase 1
Withdrawn
Conditions
Recurrent Adult Acute Lymphoblastic Leukemia
Refractory Adult Acute Lymphoblastic Leukemia
Interventions
Other: Laboratory Biomarker Analysis
Other: Pharmacological Study
First Posted Date
2016-08-10
Last Posted Date
2016-12-15
Lead Sponsor
Northwestern University
Registration Number
NCT02861040
Locations
🇺🇸

Stanford University, Palo Alto, California, United States

🇺🇸

Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath